🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Several experts said the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, risking fines, legal action or prison.

Platform Response and Content Elimination

Based on the social media company, the platform has taken down violative material and banned associated keywords and search suggestions. The company stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

After minutes of entering one community, a vendor shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, health issues or past usage.

Item Details and Costs

Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially serious medical dangers”.